Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
To meet the requirements for rapid tumor growth, a complex array of non-neoplastic cells are recruited to the tumor microenvironment. These cells facilitate tumor development by providing matrices, cytokines, growth factors, as well as vascular networks for nutrient and waste exchange, however their precise origins remain unclear. Through multicolored tissue transplant procedures; we have quantitatively determined the contribution of bone marrow-derived and adipose-derived cells to stromal populations within syngeneic ovarian and breast murine tumors. Our results indicate that subpopulations of tumor-associated fibroblasts (TAFs) are recruited from two distinct sources. The majority of fibroblast specific protein (FSP) positive and fibroblast activation protein (FAP) positive TAFs originate from mesenchymal stem/stromal cells (MSC) located in bone marrow sources, whereas most vascular and fibrovascular stroma (pericytes, α-SMA(+) myofibroblasts, and endothelial cells) originates from neighboring adipose tissue. These results highlight the capacity for tumors to utilize multiple sources of structural cells in a systematic and discriminative manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“MSC can be mobilized and recruited to active tumor sites, where they can incorporate into the tumor’s microenvironment [5, 68, 100–103].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725 · cited 1×
“The existence of a circulating bone marrow-derived endothelial progenitor (BM EPC) has been a topic of controversy for the past decade, dating back to its initial description by Asahara and colleagues in 1997 [39].”
BackgroundMultilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P., & Hedrick, M. H. (2001) · Tissue Engineering · doi:10.1089/107632701300062859 · Cited by 7,956 · cited 1×
“Within the stromal fraction of WAT, progenitors with a similar phenotype, proliferative rate and differential capacity to BM MSC have been identified [47,54].”
BackgroundOverweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696 · cited 1×
“Obesity has been determined as a predisposing factor for cancer development and is associated with poor prognosis of certain cancer types [50].”
BackgroundKern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0342 · Cited by 3,370
Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., & Isner, J. M. (1999) · Circulation Research · doi:10.1161/01.res.85.3.221 · Cited by 3,253 · cited 2×
“BM EPC have been reported to contribute significantly to tumor vasculature in many investigations [6,32,33].”
BackgroundAdipose-derived stem cells for regenerative medicine
Gimble, J. M., Katz, A. J., & Bunnell, B. A. (2007) · Circulation Research · doi:10.1161/01.res.0000265074.83288.09 · Cited by 2,332 · cited 1×
“Within the stromal fraction of WAT, progenitors with a similar phenotype, proliferative rate and differential capacity to BM MSC have been identified [47,54].”
BackgroundDistinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860 · cited 2×
“BM EPC have been reported to contribute significantly to tumor vasculature in many investigations [6,32,33].”
BackgroundDeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
De Palma, M., Venneri, M. A., Galli, R., Sergi, L. S., Politi, L. S., Sampaolesi, M., & Naldini, L. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.002 · Cited by 1,311
Research works printed but not linked: 1
- Studeny M Marini FC Zompetta C Champlin RE Filder IJ 2001 Bone marrow derived mesenchymal stem cells serve as precursors for stromal fibroblasts in malignant tumors and show potential for cancer therapy. Blood 9 697a
Cited by
The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence
Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3958 · Cited by 2,144
Diversity and biology of cancer-associated fibroblasts
Biffi, G., & Tuveson, D. A. (2021) · Physiological Reviews · doi:10.1152/physrev.00048.2019 · Cited by 1,265
Fibroblast heterogeneity in the cancer wound
Öhlund, D., Elyada, E., & Tuveson, D. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140692 · Cited by 926
Bresnick, A. R., Weber, D. J., & Zimmer, D. B. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3893 · Cited by 822
The myofibroblast matrix: implications for tissue repair and fibrosis
Klingberg, F., Hinz, B., & White, E. S. (2013) · The Journal of Pathology · doi:10.1002/path.4104 · Cited by 776
“A number of recent reviews have considered the nature of myofibroblastprogenitors in different organs [21], including resident fibroblasts [3,19,22-25], fibrocytes[26-28],smooth muscle cells [29], pericytes[30-33], epithelial and endothelial cells undergoing endothelial (EndoMT) or epithelial-to-mesenchymal transition…”
Tumor-associated stromal cells as key contributors to the tumor microenvironment
Bussard, K. M., Mutkus, L., Stumpf, K., Gomez-Manzano, C., & Marini, F. C. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0740-2 · Cited by 746
“We and others have demonstrated that the cellular origin of tumor-associated stroma may shape the phenotypic and biological characteristics of TASCs and, in turn, contribute to the appearance of tumor-associated stroma as a heterogeneous cell population with distinct subtypes that express specific cellular markers [1].”
BackgroundSelf-citationMonteran, L., & Erez, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01835 · Cited by 675
Cancer-associated fibroblasts in the single-cell era
Lavie, D., Ben-Shmuel, A., Erez, N., & Scherz-Shouval, R. (2022) · Nature Cancer · doi:10.1038/s43018-022-00411-z · Cited by 616
Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy
Baglio, S. R., Pegtel, D. M., & Baldini, N. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00359 · Cited by 542
“While the soluble secretome of MSCs is partly characterized (Parekkadan et al., 2007; Lee et al., 2010; Roche et al., 2012), it seems unlikely that specific cytokines and growth factors alone give MSCs their remarkable healing abilities.”
BackgroundAspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalaf, K., Hana, D., Chou, J. T.-T., Singh, C., Mackiewicz, A., & Kaczmarek, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656364 · Cited by 513
Fibroblasts in cancer: Unity in heterogeneity
Chhabra, Y., & Weeraratna, A. T. (2023) · Cell · doi:10.1016/j.cell.2023.03.016 · Cited by 474
Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment
Augsten, M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00062 · Cited by 427
Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts
Ziani, L., Chouaib, S., & Thiery, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00414 · Cited by 381
“Moreover, in breast cancer, adipocytes were shown to differentiate in CAFs (41, 42).”
BackgroundBiodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells
Leibacher, J., & Henschler, R. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0271-2 · Cited by 367
“[90] showed that tumor-associated fibroblasts originating from transplanted”
BackgroundThe role of reactive oxygen species and metabolism on cancer cells and their microenvironment
Costa, A., Scholer-Dahirel, A., & Mechta-Grigoriou, F. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.12.007 · Cited by 324
“Moreover, various mesenchymal cell types, including endothelial cells, pericytes or pre-adipocytes can also be converted into myofibroblasts in breast carcinomas [56,64,65].”
BackgroundStromal Cells in the Tumor Microenvironment
Denton, A. E., Roberts, E. W., & Fearon, D. T. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-78127-3_6 · Cited by 306
Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities
Hu, D., Li, Z., Zheng, B., Lin, X., Pan, Y., Gong, P., Zhuo, W., Hu, Y., Chen, C., Chen, L., et al. (2022) · Cancer Communications · doi:10.1002/cac2.12291 · Cited by 286
“[157] identified the origin of the majority of FSP1-positive and FAP-positive CAFs as marrow-derived MSCs.”
BackgroundReciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance
Jacamo, R., Chen, Y., Wang, Z., Ma, W., Zhang, M., Spaeth, E. L., Wang, Y., Battula, V. L., Mak, P. Y., Schallmoser, K., et al. (2014) · Blood · doi:10.1182/blood-2013-06-511527 · Cited by 282
Self-citationThe evolution of the cancer niche during multistage carcinogenesis
Barcellos-Hoff, M. H., Lyden, D., & Wang, T. C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3536 · Cited by 279
Yang, J., Liu, X.-X., Fan, H., Tang, Q., Shou, Z.-X., Zuo, D.-M., Zou, Z., Xu, M., Chen, Q.-Y., Peng, Y., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0140551 · Cited by 277
“However, as research continues, various studies have indicated these cells acted as potential sources of tumor associated fibroblasts (TAFs) [5] and have been found in many tumors including gastric lipoma[6], adenocarcinoma[7] and osteosarcoma[8], strongly suggesting their involvement in the process of tumor developme…”
BackgroundFibroblasts as architects of cancer pathogenesis
Marsh, T., Pietras, K., & McAllister, S. S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.10.013 · Cited by 264
“~27% of the NG2-positive cells [69].”
Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
Mhaidly, R., & Mechta-Grigoriou, F. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101417 · Cited by 259
Mhaidly, R., & Mechta‐Grigoriou, F. (2021) · Immunological Reviews · doi:10.1111/imr.12978 · Cited by 231
The role of the myofibroblast in tumor stroma remodeling
Otranto, M., Sarrazy, V., Bonté, F., Hinz, B., Gabbiani, G., & Desmouliere, A. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20377 · Cited by 250
“However, the tumor environment seems to activate MSCs to myofibroblasts similar to other precursor cells.(117,140,141) BM-MSCs cultured in tumor-conditioned medium differentiate into a-SMA-positive myofibroblasts.”
The roles of mesenchymal stem cells in tumor inflammatory microenvironment
Sun, Z., Wang, S., & Zhao, R. C. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-14 · Cited by 249
“However, compared to MSCs, TAFs secrete significantly higher levels of TGF-β, VEGF, IL-4, and IL-10 [41,42]; moreover, TAFs express various specific markers such as α-smooth muscle actin (α-SMA), PDGF receptor-β (PDGFR-β), desmin, fibroblast-specific protein (FSP), and fibroblast activation protein (FAP) [26,43-46].”
BackgroundInfluentialFibroblasts in the Tumor Microenvironment: Shield or Spear?
Alkasalias, T., Moyano-Galceran, L., Arsenian-Henriksson, M., & Lehti, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051532 · Cited by 247
“the adipocytes have also been suggested to represent a source of CAFs [77].”
BackgroundZhang, T., Lee, Y. W., Rui, Y. F., Cheng, T. Y., Jiang, X. H., & Li, G. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt221 · Cited by 234
“Various different mobilized cell types including normal fibroblasts, preadipocytes, epithelial cells and smooth muscle cells have been shown to be the sources of CAFs [11].”
BackgroundInfluentialZhang, Y., Daquinag, A. C., Amaya-Manzanares, F., Sirin, O., Tseng, C., & Kolonin, M. G. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0294 · Cited by 233
“In addition, expression of a-SMA, a perivascular marker expressed on ASCs (7, 14, 23), was more abundant on perivascular GFPþ cells in obese mice (Fig.”
BackgroundLiu, F., Qi, L., Liu, B., Liu, J., Zhang, H., Che, D., Cao, J., Shen, J., Geng, J., Bi, Y., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116683 · Cited by 227
Multiple Targets of the Canonical WNT/β-Catenin Signaling in Cancers
Lecarpentier, Y., Schussler, O., Hébert, J.-L., & Vallée, A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01248 · Cited by 224
Weber, C. E., Kothari, A. N., Wai, P. Y., Li, N. Y., Driver, J., Zapf, M. A. C., Franzen, C. A., Gupta, G. N., Osipo, C., Zlobin, A., et al. (2015) · Oncogene · doi:10.1038/onc.2014.410 · Cited by 226
Tomasetti, M., Lee, W., Santarelli, L., & Neuzil, J. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.153 · Cited by 216
Carcinoma‐associated fibroblasts: Non‐neoplastic tumour‐promoting mesenchymal cells
Polanska, U. M., & Orimo, A. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24347 · Cited by 208
“CAFs promote tumour progression by exerting an influence on ECM in the TME (Levental et al., 2009; Kobayashi et al., 2010).”
BackgroundMesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression
Rhee, K.-J., Lee, J., & Eom, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226215 · Cited by 214
“By contrast, it has been reported that different MSCs isolated from two distinct tissues can be recruited into tumor microenvironments, and the different MSC types can be more prompt to transdifferentiate into determined cell types [10].”
BackgroundCancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment
Houthuijzen, J. M., & Jonkers, J. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9768-3 · Cited by 205
Mesenchymal stem cells in tumor development: Emerging roles and concepts
Cuiffo, B. G., & Karnoub, A. E. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20875 · Cited by 201
CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia
Chen, Y., Jacamo, R., Konopleva, M., Garzon, R., Croce, C., & Andreeff, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66553 · Cited by 202
“Spectral images were obtained using a Cambridge Research and Instrumentation attachment on an Olympus IX81 microscope with a disc-scanning unit confocal attachment, and images were analyzed using InForm software as described previously (55).”
Self-citationMesenchymal Cells in Colon Cancer
Koliaraki, V., Pallangyo, C. K., Greten, F. R., & Kollias, G. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.049 · Cited by 199
S100A4 in cancer progression and metastasis: A systematic review
Fei, F., Qu, J., Zhang, M., Li, Y., & Zhang, S. (2017) · Oncotarget · doi:10.18632/oncotarget.18016 · Cited by 199
“Most of S100A4+ stromal cells are derived from bone marrow [66] and the recruitment of CD45+ leukocytes and CD3+ T lymphocytes to tumor lesions is clearly reduced [49] in the breast tumor microenvironment.”
BackgroundContribution of adipose tissue to development of cancer
Cozzo, A. J., Fuller, A. M., & Makowski, L. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170008 · Cited by 188
“Kidd et al. (200) investigated the relative contribution of ASCs versus bone marrow-derived stem cells to stromal populations in mouse models of ovarian and breast cancers, and found that the majority (greater than 70”
MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis
Cook, R. S., Jacobsen, K. M., Wofford, A. M., DeRyckere, D., Stanford, J., Prieto, A. L., Redente, E., Sandahl, M., Hunter, D. M., Strunk, K. E., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67655 · Cited by 184
“Because bone marrow–derived mesenchymal stem cells might give rise to fibroblasts in the tumor microenvironment that could modulate tumor growth and metastasis (45), we investigated the impact of MerTK –/– fibroblasts in the tumor microenvironment.”
Thibault, B., Castells, M., Delord, J.-P., & Couderc, B. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9456-2 · Cited by 184
“[180].”
Ding, L., Ren, J., Zhang, D., Li, Y., Huang, X., Hu, Q., Wang, H., Song, Y., Ni, Y., & Hou, Y. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy006 · Cited by 184
“The CAF are mainly derived and activated from normal fibroblasts (NFs), and bone marrow-derived mesenchymal stem cells (9), circulating fibrocytes (10), tissue adipocytes (11) and endothelial cells (12) are also acquire fibroblast markers during carcinogenesis and other inflammatory environment.”
Tumor microenvironment: Bone marrow-mesenchymal stem cells as key players
Barcellos-de-Souza, P., Gori, V., Bambi, F., & Chiarugi, P. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.10.004 · Cited by 180
“, and it was proposed that themajority of the pericytes (neuron/glial antigen (NG)2 andα-SMA) and endothelial cells (CD31) are recruited from the tumor adjacent tissue, such as local adipose tissue, whereas the FAP and FSP CAF-like cells, involved in extracellular matrix remodeling, are attracted from the host bone ma…”
BackgroundMethodBorriello, L., Nakata, R., Sheard, M. A., Fernandez, G. E., Sposto, R., Malvar, J., Blavier, L., Shimada, H., Asgharzadeh, S., Seeger, R. C., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2586 · Cited by 180
“In contrast, aSMA, NG2, and CD31positive cells were found to originate from the surrounding adipose tissues (30).”
Mesenchymal stem cell secretome and regenerative therapy after cancer
Zimmerlin, L., Park, T. S., Zambidis, E. T., Donnenberg, V. S., & Donnenberg, A. D. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.010 · Cited by 168
“Both BM-MSC and adipose-resident cells have been shown to be recruited to sites of ovarian tumors, where BM-MSC preferentially give rise to tumor-associated fibroblasts (TAF) while the adipose stroma contributes to vascular/fibrovascular lineages [68].”
BackgroundZhao, Q., Gregory, C. A., Lee, R. H., Reger, R. L., Qin, L., Hai, B., Park, M. S., Yoon, N., Clough, B., McNeill, E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423008112 · Cited by 164
“Also, endogenous MSCs are a major source of reactive stromal cells that promote growth and metastasis of cancers (4, 24).”
BackgroundRecent advances in understanding tumor stroma-mediated chemoresistance in breast cancer
Plava, J., Cihova, M., Burikova, M., Matuskova, M., Kucerova, L., & Miklikova, S. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0960-z · Cited by 164
“In addition, MSCs in TME can easily differentiate into CAFs [41], and MSC-like CAFs that express FSP and FAP [42] originate from BM-MSCs whereas the AT-MSCs mainly differentiate into vascular and fibro-vascular stromal cells [43, 44].”
BackgroundTargeting fibroblast activation protein in cancer ndash Prospects and caveats
Sedo, A. (2018) · Frontiers in Bioscience · doi:10.2741/4682 · Cited by 161
“To conclude, the frequently observed upregulation of FAP in cancer tissue seems to be the result of a complex paracrine and/or juxtacrine communication between the transformed cells and their microenvironment, of the recruitment of bone marrow-derived mesenchymal stem cells (174), and of an activation of the epithelia…”
BackgroundZhang, T., Tseng, C., Zhang, Y., Sirin, O., Corn, P. G., Li-Ning-Tapia, E. M., Troncoso, P., Davis, J., Pettaway, C., Ward, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms11674 · Cited by 160
“Expression of a SMA, a myofibroblast marker 13 , is higher in CAFs derived from ASCs, as compared with CAFs derived from the bone marrow 20 .”
InfluentialHigashino, N., Koma, Y.-I., Hosono, M., Takase, N., Okamoto, M., Kodaira, H., Nishio, M., Shigeoka, M., Kakeji, Y., & Yokozaki, H. (2019) · Laboratory Investigation · doi:10.1038/s41374-018-0185-6 · Cited by 158
Carcinoma-Associated Fibroblasts Are a Promising Therapeutic Target
Togo, S., Polanska, U., Horimoto, Y., & Orimo, A. (2013) · Cancers · doi:10.3390/cancers5010149 · Cited by 156
“In contrast, -SMA + and NG2 + myofibroblasts in tumour started to develop mainly from RFP + local resident tissue exemplified by the adipose tissue [19].”
BackgroundHOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
Teschendorff, A. E., Lee, S.-H., Jones, A., Fiegl, H., Kalwa, M., Wagner, W., Chindera, K., Evans, I., Dubeau, L., Orjalo, A., et al. (2015) · Genome Medicine · doi:10.1186/s13073-015-0233-4 · Cited by 152
“On the other hand the cancer cell-autonomous tumour stroma and mesenchymal stem cells (MSCs) — mainly recruited from the bone marrow [6] — might play an important role in ovarian cancer biology [7, 8].”
Cancer-Associated Fibroblasts: Understanding Their Heterogeneity
Louault, K., Li, R.-R., & DeClerck, Y. A. (2020) · Cancers · doi:10.3390/cancers12113108 · Cited by 148
Yin, W., Wang, J., Jiang, L., & Kang, Y. J. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211005390 · Cited by 222
“Recent studies have reported a detection of a population of MSCs that was recruited from nearby or distant tissues to tumor, promoting tumor growth and increasing metastatic potential.(44) Given that MSCs are well known for their abilities of proliferation, migration and differentiation, it can be speculated that MSCs…”
BackgroundInfluentialImplanted adipose progenitor cells as physicochemical regulators of breast cancer
Chandler, E. M., Seo, B. R., Califano, J. P., Andresen Eguiluz, R. C., Lee, J. S., Yoon, C. J., Tims, D. T., Wang, J. X., Cheng, L., Mohanan, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121160109 · Cited by 147
“Specifically, approximately 20% of tumor-associated α-smooth muscle actin (α-SMA) positive myofibroblasts originate from bone marrow, whereas nonbone marrow tissues including adipose tissue contribute to the remainder (13, 14); however, the integrated effects of tumor-associated physicochemical cues on ASC-dependent t…”
BackgroundBlocki, A., Wang, Y., Koch, M., Peh, P., Beyer, S., Law, P., Hui, J., & Raghunath, M. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0415 · Cited by 143
“Indeed, during tumor angiogenesis [3,15,16] and wound healing [17], pericytes are recruited from both the nonlesional vicinity of tissue and the bone marrow (bm) to facilitate blood vessel formation.”
Orecchioni, S., Reggiani, F., Talarico, G., Mancuso, P., Calleri, A., Gregato, G., Labanca, V., Noonan, D. M., Dallaglio, K., Albini, A., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29193 · Cited by 139
TGF-β and mesenchymal stromal cells in regenerative medicine, autoimmunity and cancer
de Araújo Farias, V., Carrillo-Gálvez, A. B., Martín, F., & Anderson, P. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.06.002 · Cited by 138
Mesenchymal stem cells: From regeneration to cancer
Li, P., Gong, Z., Shultz, L. D., & Ren, G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.005 · Cited by 134
“In a syngeneic mouse model of ovarian cancer, the origins of TAFs in the tumor microenvironment have been quantitatively assessed in vivo (Kidd et al., 2012).”
BackgroundCarcinoma-associated fibroblasts provide operational flexibility in metastasis
Wever, O. D., Bockstal, M. V., Mareel, M., Hendrix, A., & Bracke, M. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.12.009 · Cited by 151
From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts
Arpinati, L., & Scherz‐Shouval, R. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.01.007 · Cited by 140
Management and potentialities of primary cancer cultures in preclinical and translational studies
Miserocchi, G., Mercatali, L., Liverani, C., De Vita, A., Spadazzi, C., Pieri, F., Bongiovanni, A., Recine, F., Amadori, D., & Ibrahim, T. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1328-z · Cited by 123
Morton, J. J., Bird, G., Keysar, S. B., Astling, D. P., Lyons, T. R., Anderson, R. T., Glogowska, M. J., Estes, P., Eagles, J. R., Le, P. N., et al. (2016) · Oncogene · doi:10.1038/onc.2015.94 · Cited by 121
“The stroma that forms in a developing tumor has two primary cellular origins: (1) mesenchymal and immune cells originating from the bone marrow, and (2) fibroblasts and other cell types from local tissues (23).”
BackgroundStrong, A. L., Strong, T. A., Rhodes, L. V., Semon, J. A., Zhang, X., Shi, Z., Zhang, S., Gimble, J. M., Burow, M. E., & Bunnell, B. A. (2013) · Breast Cancer Research · doi:10.1186/bcr3569 · Cited by 119
“ASCs are mesenchymal lineage stem cells that are recruited to the tumor or sites of inflammation and are essential components that establish the tumor microenvironment [11-13].”
BackgroundNowicka, A., Marini, F. C., Solley, T. N., Elizondo, P. B., Zhang, Y., Sharp, H. J., Broaddus, R., Kolonin, M., Mok, S. C., Thompson, M. S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081859 · Cited by 119
“These differences in lineage markers may reflect the different differentiation potential of ASCs and MSCs which has been shown to occur within tumors and normal tissues [15].”
BackgroundSelf-citationAntifibrotic therapy to normalize the tumor microenvironment
Hauge, A., & Rofstad, E. K. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02376-y · Cited by 114
Role of CD36 in cancer progression, stemness, and targeting
Guerrero-Rodríguez, S., Mata-Cruz, C., Pérez‐Tapia, S. M., & Velasco-Velázquez, M. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1079076 · Cited by 133
“Endogenous normal cells are frequently recruited into the tumor (Kidd et al., 2012).”
BackgroundRivera-Cruz, C. M., Shearer, J. J., Figueiredo Neto, M., & Figueiredo, M. L. (2017) · Stem Cells International · doi:10.1155/2017/4015039 · Cited by 113
“MSCs that infiltrate tumors come from local or distant sources [13] and may differentiate and/or transdifferentiate into normal resident cells in an attempt to contribute to tissue repair (Figure 1(a)).”
BackgroundKoczorowska, M. M., Tholen, S., Bucher, F., Lutz, L., Kizhakkedathu, J. N., De Wever, O., Wellner, U. F., Biniossek, M. L., Stahl, A., Lassmann, S., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2015.08.001 · Cited by 112
Orecchioni, S., Gregato, G., Martin-Padura, I., Reggiani, F., Braidotti, P., Mancuso, P., Calleri, A., Quarna, J., Marighetti, P., Aldeni, C., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0821 · Cited by 111
Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?
Puré, E., & Lo, A. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0011 · Cited by 111
“Additionally, bone marrow–derived fibrocytes or MSCs can be recruited into tumors and differentiate into CAFs (30, 39, 42, 43).”
BackgroundHouthuijzen, J. M., de Bruijn, R., van der Burg, E., Drenth, A. P., Wientjens, E., Filipovic, T., Bullock, E., Brambillasca, C. S., Pulver, E. M., Nieuwland, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35793-w · Cited by 120
Epithelial and stromal co-evolution and complicity in pancreatic cancer
Hingorani, S. R. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00530-w · Cited by 108
Paracrine tumor signaling induces transdifferentiation of surrounding fibroblasts
Heneberg, P. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.09.008 · Cited by 110
“Additionally, bone marrow-derived fibrocytes can be recruited to the tumor and differentiate into either myofibroblasts or CAFs (Ishii et al., 2003; Direkze et al., 2004; Mishra et al., 2008; Kidd et al., 2012).”
BackgroundThe Role of Adipose-Derived Stem Cells in Breast Cancer Progression and Metastasis
Schweizer, R., Tsuji, W., Gorantla, V. S., Marra, K. G., Rubin, J. P., & Plock, J. A. (2015) · Stem Cells International · doi:10.1155/2015/120949 · Cited by 110
“MSCs are able to home to sites of tissue injury and inflammation [20], as well as the cancer microenvironment (CME) [21, 22].”
BackgroundInfluentialSalimian Rizi, B., Caneba, C., Nowicka, A., Nabiyar, A. W., Liu, X., Chen, K., Klopp, A., & Nagrath, D. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1337 · Cited by 98
Self-citationLevesque, C., & Nelson, P. S. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030510 · Cited by 107
“It is possible that the expression changes in tumor stroma arise as responses to extrinsic signals as a reciprocal coevolution of the tumor microenvironment through the progression of the malignancy possibly by trafficking of bone marrow–derived mesenchymal cells that take up residence in the prostate microenvironment…”
BackgroundZhou, X., Li, T., Chen, Y., Zhang, N., Wang, P., Liang, Y., Long, M., Liu, H., Mao, J., Liu, Q., et al. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4747 · Cited by 107
“Several studies have demonstrated that MSCs can also contribute to the formation of the tumor microenvironment (17-20).”
BackgroundFibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging
Peltier, A., Seban, R., Buvat, I., Bidard, F., & Mechta‐Grigoriou, F. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.04.008 · Cited by 102
The Role of the Tumor Microenvironment and Treatment Strategies in Colorectal Cancer
Chen, Y., Zheng, X., & Wu, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.792691 · Cited by 117
Mesenchymal stem cell-derived exosomes facilitate nasopharyngeal carcinoma progression.
Shi, S., Zhang, Q., Xia, Y., You, B., Shan, Y., Bao, L., Li, L., You, Y., & Gu, Z. (2016) · PubMed Central · Cited by 113
Vaish, U., Jain, T., Are, A. C., & Dudeja, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413408 · Cited by 111
“have studied generation of adipocyte-derived CAFs in a murine breast-cancer model using GFP+ adipocytes, and found that α-smooth muscle actin or (αSMA+) tumor stroma were generated from the local adipose tissue [30].”
BackgroundThe Role of Fibroblasts in Skin Homeostasis and Repair
Boraldi, F., Lofaro, F. D., Bonacorsi, S., Mazzilli, A., Garcia‐Fernandez, M. I., & Quaglino, D. (2024) · Biomedicines · doi:10.3390/biomedicines12071586 · Cited by 127
Mesenchymal stem cells in the tumor microenvironment
GUAN, J., & Chen, J. (2013) · Biomedical Reports · doi:10.3892/br.2013.103 · Cited by 102
Kučerová, L., Miklikova, S., Matúšková, M., Boháč, M., & Kozovská, Z. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-535 · Cited by 102
“MSCs from both sources were demonstrated to integrate into tumor-associated stroma and exhibit multiple regulatory functions in the tumor microenvironment [10-12].”
BackgroundIL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma
Pandey, S., Mourcin, F., Marchand, T., Nayar, S., Guirriec, M., Pangault, C., Monvoisin, C., Amé-Thomas, P., Guilloton, F., Dulong, J., et al. (2017) · Blood · doi:10.1182/blood-2016-08-737239 · Cited by 101
Wang, J., Wang, Y., Wang, S., Cai, J., Shi, J., Sui, X. Y., Cao, Y., Huang, W., Chen, X., Cai, Z., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5739 · Cited by 100
Chen, L., Liu, J.-F., Lu, Y., He, X., Zhang, C., & Zhou, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.642144 · Cited by 92
“Studies have shown that stromal cells are involved in tumor angiogenesis and extracellular matrix remodeling (8).”
BackgroundSpaeth, E. L., LaBaff, A. M., Toole, B. P., Klopp, A. H., Andreeff, M., & Marini, F. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0087 · Cited by 97
“proteoglycan (NG2); the other that is defined by a fibroblastic role, termed an activated fibroblast and defined by the expression of the seprase, fibroblast activation protein (FAP) and the calcium binding protein, fibroblast specific protein (FSP).(5)”
BackgroundSelf-citationMatrix mechanics and regulation of the fibroblast phenotype
Hinz, B. (2013) · Periodontology 2000 · doi:10.1111/prd.12030 · Cited by 90
Stem cells from adipose tissue and breast cancer: hype, risks and hope
Bertolini, F., Petit, J.-Y., & Kolonin, M. G. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.657 · Cited by 93
“Stem cells from adipose tissue and breast cancer: hype, risks and hope”
BackgroundMesenchymal Stem Cells Induce Directional Migration of Invasive Breast Cancer Cells through TGF-β
McAndrews, K. M., McGrail, D. J., Ravikumar, N., & Dawson, M. R. (2015) · Scientific Reports · doi:10.1038/srep16941 · Cited by 89
Miyazaki, Y., Oda, T., Mori, N., & Kida, Y. S. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12976 · Cited by 86
Obesity and prostate cancer — microenvironmental roles of adipose tissue
Saha, A., Kolonin, M. G., & DiGiovanni, J. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00764-9 · Cited by 92
Obesity and renal cancer: Role of adipokines in the tumor-immune system conflict
Gati, A., Kouidhi, S., Marrakchi, R., El Gaaied, A., Kourda, N., Derouiche, A., Chebil, M., Caignard, A., & Perier, A. (2014) · OncoImmunology · doi:10.4161/onci.27810 · Cited by 85
“These cells substantially affect the tumor biology due to their ability to accumulate within the tumor stroma and to exert multiple regulatory functions in the tumor microenvironment.(50,51) AT-derived MSCs share a number of key characteristics with bone marrow-derived MSCs.”
BackgroundThe function of natural compounds in important anticancer mechanisms
Nan, Y., Su, H., Zhou, B., & Liu, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1049888 · Cited by 98
Wang, H.-H., Cui, Y.-L., Zaorsky, N. G., Lan, J., Deng, L., Zeng, X.-L., Wu, Z.-Q., Tao, Z., Guo, W.-H., Wang, Q.-X., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.033 · Cited by 86
Functional implications of Rab27 GTPases in Cancer
Li, Z., Fang, R., Fang, J. S., He, S., & Liu, T. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0255-9 · Cited by 89
de Lourdes Mora-García, M., García-Rocha, R., Morales-Ramírez, O., Montesinos, J. J., Weiss-Steider, B., Hernández-Montes, J., Ávila-Ibarra, L. R., Don-López, C. A., Velasco-Velázquez, M. A., Gutiérrez-Serrano, V., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1057-8 · Cited by 77
“Other studies have found that TGF-β and SDF-α cytokines as well as CXCR6 are important mediators of the migration of BM-MSCs to the tumor microenvironment [54].”
BackgroundInfluential
Metadata
- Authors
- Kidd, S., Spaeth, E., Watson, K., Burks, J., Lu, H., Klopp, A., Andreeff, M., & Marini, F. C.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Marini, Frank C.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-02-20
- Volume
- 7
- Issue
- 2
- Pages
- e30563
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3282707
- OpenAlex
- W1972938311
- Cited by
- 371
- References
- 58
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 19 · 2023: 32 · 2022: 24 · 2021: 30 · 2020: 23 · 2019: 29 · 2018: 22 · 2017: 21 · 2016: 30 · 2015: 32 · 2014: 34 · 2013: 44 · 2012: 18
- FWCI
- 20.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- U.S. Department of Defense
- Ovarian Cancer Research Fund
- Susan G. Komen (BC083397)
- National Cancer Institute (P50CA116199, CA-16672, CA-55164, R01CA109451, P01CA049639, R01NS06994, P01CA055164, Ca-116199, RC1CA146381, BC083397, CA109451, P50CA083639, P30CA016672, CA 49639)
- National Institute of Neurological Disorders and Stroke (R01NS069964, R01NS06994)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- tumor microenvironment, cancer-associated fibroblasts, mesenchymal stem cells, pericytes, myofibroblasts, endothelial cells, fibroblast activation protein, ovarian neoplasms, breast tumors, tissue transplantation
- MeSH terms
- Adipose Tissue, Animals, Bone Marrow Cells, Female, Mice, Inbred C57BL, Models, Biological, Biomarkers, Cell Line, Tumor, Green Fluorescent Proteins, Mice, Tumor Microenvironment, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.